Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Pain × Mitoxantrone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Leukemia, Myeloid, Acute 31 Precursor Cell Lymphoblastic Leukemia-Lymphoma 12 Leukemia 10 Prostatic Neoplasms 9 Lymphoma 8 Leukemia, Erythroblastic, Acute 8 Leukemia, Myelomonocytic, Acute 7 Leukemia, Monocytic, Acute 7 Congenital Abnormalities 7 Lymphoma, Follicular 6 Leukemia, Megakaryoblastic, Acute 6 Leukemia, Biphenotypic, Acute 5 Myelodysplastic Syndromes 4 Lymphoma, Non-Hodgkin 4 Sarcoma, Myeloid 2 Recurrence 2 Neoplasms 2 Myeloproliferative Disorders 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Leukemia, Eosinophilic, Acute 2 Leukemia, Basophilic, Acute 2 Waldenstrom Macroglobulinemia 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1 Pain 1 Myeloid Malignancies 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, B-Cell, Marginal Zone 1 Leukemia, T-Cell 1

Interventions

Fentanyl 7 nabiximols 6 Morphine 6 Hydromorphone 6 Tapentadol 5 Prednisone 3 Methadone 3 Calcium Dobesilate 3 Acetaminophen 3 cabozantinib 2 Surveys and Questionnaires 2 Sugars 2 Radiotherapy 2 Radiosurgery 2 Pregabalin 2 Pain Management 2 Oxycodone 2 Minocycline 2 Letrozole 2 Ketamine 2 Ibuprofen 2 Duloxetine Hydrochloride 2 Diclofenac 2 Dexamethasone 2 Cryosurgery 2 Calcium Gluconate 2 Calcium 2 Analgesia 2 trimebutine 3-thiocarbamoylbenzenesulfonate 1 tandutinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01522443 2018-05-23

COMET-2

Exelixis

Phase 3 Terminated

119 enrolled 21 charts

Pain, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡